Call us free on 0800 862 0373

Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Prostate cancer sufferers with gene mutation should be offered early treatment

Published on 09/04/2013

Prostate cancer patients with a specific gene mutation should be offered early and aggressive treatment on the NHS, even if they would normally be classified as low risk, according to a new study.


Prostate cance ris the most common cancer in men in the UK

With over 40,000 new cases diagnosed every year, prostate cancer is the most common cancer in men in the UK.

Progression of prostate cancer is often slow, and not all men require immediate treatment. In fact, some low-risk sufferers may live with the disease for a lifetime without any symptoms.

However, a new study in the Journal of Clinical Oncology shows that prostate cancer patients with a particular gene mutation called BRCA2 could benefit from immediate surgery or radiotherapy, even if they are normally classed as low-risk.

Around one in every 100 men with prostate cancer will have the BRCA2 mutation.

Scientists at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust looked at the medical records of prostate cancer patients. 61 of the men had the BRCA2 mutation, and 18 had a similar gene mutation called BRCA1. They also looked at over 1,900 patients with neither mutation.

The study found that patients with BRCA2 mutations lived an average of 6.5 years after diagnosis, whilst non-carriers lived for 12.9 years. As well as having poorer survival rates, BRCA2 carriers were also more likely to develop aggressive tumours that spread quickly.

Lead researcher Professor Ros Eeles said: "It is clear from our study that prostate cancers linked to inheritance of the BRCA2 cancer gene are more deadly than other types.

"It must make sense to start offering affected men immediate surgery or radiotherapy, even for early-stage cases that would otherwise be classified as low-risk.”

The BRCA2 gene is linked to hereditary breast, prostate and ovarian cancer. Men with a significant family history of these cancers can be offered testing for BRCA1/2 at diagnosis of prostate cancer. However, testing is not routinely offered in the UK.

The scientists hope that earlier treatment will benefit men with inherited cancer genes, and are planning to test the theory in a clinical trial.

If you want access to cancer treatment on your private health insurance policy, look for a plan with comprehensive cancer cover.

© ActiveQuote Ltd. 2013


Categories:  HealthMedical
Prostate cancer sufferers with gene mutation should be offered early treatmentProstate cancer patients with a specific gene mutation should be offered early and aggressive treatment on the NHS, even if they would norma    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile
 

No.1 health insurance broker as rated by customers

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member
 
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...